Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia.

Hart, S; Goh, K C; Novotny-Diermayr, V; Tan, Y C; Madan, B; Amalini, C; Ong, L C; Kheng, B; Cheong, A; Zhou, J; Chng, W J; Wood, J M

Hart, S; Goh, K C; Novotny-Diermayr, V; Tan, Y C; Madan, B; Amalini, C; Ong, L C; Kheng, B; Cheong, A; Zhou, J; Chng, W J; Wood, J M.

Blood Cancer J ; 1(11): e44, 2011 Nov.

Article in En | MEDLINE | ID: mdl-22829080

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256753
https://dx.doi.org/10.1038/bcj.2011.43

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Blood Cancer J Year: 2011 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256753
https://dx.doi.org/10.1038/bcj.2011.43

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Blood Cancer J Year: 2011 Document type: Article